建立多发性硬化恢复力量表的测试-复验可靠性和最小可检测变化。

Q1 Nursing International journal of MS care Pub Date : 2023-01-01 Epub Date: 2022-09-07 DOI:10.7224/1537-2073.2021-126
Elizabeth S Gromisch, Aaron P Turner, Lindsay O Neto, Jennifer A Ruiz, Albert C Lo, Thomas Agresta, Frederick W Foley
{"title":"建立多发性硬化恢复力量表的测试-复验可靠性和最小可检测变化。","authors":"Elizabeth S Gromisch,&nbsp;Aaron P Turner,&nbsp;Lindsay O Neto,&nbsp;Jennifer A Ruiz,&nbsp;Albert C Lo,&nbsp;Thomas Agresta,&nbsp;Frederick W Foley","doi":"10.7224/1537-2073.2021-126","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Multiple Sclerosis Resiliency Scale (MSRS) was designed to assess factors connected to resilience when facing MS-related challenges. Although the MSRS has demonstrated good internal consistency and construct validity, its test-retest reliability has yet to be established. Identifying the minimal detectable change (MDC) of the scale will also improve its utility as an outcome measure for resilience-based interventions. This study aimed to determine the test-retest reliability and MDC of the MSRS.</p><p><strong>Methods: </strong>Participants were 62 persons with MS who completed the MSRS twice, with a mean ± SD of 16.60 ± 3.97 days (range, 14-30 days) between assessments. Test-retest reliability was evaluated using a 2-way, random-effects, single-measurement intraclass correlation coefficient (ICC), with agreement between time 1 and time 2 visualized with a Bland-Altman plot. The MDC was calculated using the standard error of measurement with a 95% CI.</p><p><strong>Results: </strong>At time 1, the mean ± SD MSRS score was 77.19 ± 11.97 (range, 45.83-97.00); at time 2, the mean ± SD score was 76.38 ± 12.75 (range, 46-98). The MSRS total score had good test-retest reliability (ICC = 0.88), with the subscale ICCs ranging from 0.77 (MS Peer Support) to 0.93 (Spirituality). The MDC for the total score was 11.95.</p><p><strong>Conclusions: </strong>These findings suggest that the MSRS has good test-retest reliability and that persons with MS with a difference of 12 points or more between assessments have experienced a reliable change. The results support the utility of the MSRS as a potential outcome measure for MS-related resilience.</p>","PeriodicalId":14150,"journal":{"name":"International journal of MS care","volume":"25 1","pages":"15-19"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881417/pdf/i1537-2073-25-1-15.pdf","citationCount":"1","resultStr":"{\"title\":\"Establishing the Test-Retest Reliability and Minimal Detectable Change of the Multiple Sclerosis Resiliency Scale.\",\"authors\":\"Elizabeth S Gromisch,&nbsp;Aaron P Turner,&nbsp;Lindsay O Neto,&nbsp;Jennifer A Ruiz,&nbsp;Albert C Lo,&nbsp;Thomas Agresta,&nbsp;Frederick W Foley\",\"doi\":\"10.7224/1537-2073.2021-126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The Multiple Sclerosis Resiliency Scale (MSRS) was designed to assess factors connected to resilience when facing MS-related challenges. Although the MSRS has demonstrated good internal consistency and construct validity, its test-retest reliability has yet to be established. Identifying the minimal detectable change (MDC) of the scale will also improve its utility as an outcome measure for resilience-based interventions. This study aimed to determine the test-retest reliability and MDC of the MSRS.</p><p><strong>Methods: </strong>Participants were 62 persons with MS who completed the MSRS twice, with a mean ± SD of 16.60 ± 3.97 days (range, 14-30 days) between assessments. Test-retest reliability was evaluated using a 2-way, random-effects, single-measurement intraclass correlation coefficient (ICC), with agreement between time 1 and time 2 visualized with a Bland-Altman plot. The MDC was calculated using the standard error of measurement with a 95% CI.</p><p><strong>Results: </strong>At time 1, the mean ± SD MSRS score was 77.19 ± 11.97 (range, 45.83-97.00); at time 2, the mean ± SD score was 76.38 ± 12.75 (range, 46-98). The MSRS total score had good test-retest reliability (ICC = 0.88), with the subscale ICCs ranging from 0.77 (MS Peer Support) to 0.93 (Spirituality). The MDC for the total score was 11.95.</p><p><strong>Conclusions: </strong>These findings suggest that the MSRS has good test-retest reliability and that persons with MS with a difference of 12 points or more between assessments have experienced a reliable change. The results support the utility of the MSRS as a potential outcome measure for MS-related resilience.</p>\",\"PeriodicalId\":14150,\"journal\":{\"name\":\"International journal of MS care\",\"volume\":\"25 1\",\"pages\":\"15-19\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881417/pdf/i1537-2073-25-1-15.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of MS care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7224/1537-2073.2021-126\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/9/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of MS care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7224/1537-2073.2021-126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 1

摘要

背景:多发性硬化症恢复力量表(MSRS)旨在评估在面临MS相关挑战时与恢复力相关的因素。尽管MSRS已经证明了良好的内部一致性和结构有效性,但其重新测试的可靠性尚待确定。确定量表的最小可检测变化(MDC)也将提高其作为基于复原力的干预措施的结果衡量标准的效用。本研究旨在确定MSRS的重测可靠性和MDC。方法:参与者为62名MS患者,他们完成了两次MSRS,两次评估之间的平均±SD为16.60±3.97天(范围为14-30天)。使用双向随机效应单次测量组内相关系数(ICC)评估测试-再测试的可靠性,时间1和时间2之间的一致性通过Bland-Altman图进行可视化。MDC采用95%置信区间的标准测量误差计算。结果:在时间1,平均±SD MSRS评分为77.19±11.97(范围为45.83-97.00);在时间2,平均±SD评分为76.38±12.75(范围46-98)。MSRS总分具有良好的重测可靠性(ICC=0.88),分量表ICCs在0.77(MS同伴支持)到0.93(精神)之间。总分的MDC为11.95。结论:这些发现表明MSRS具有良好的重测可靠性,并且两次评估之间相差12分或更多的MS患者经历了可靠的变化。研究结果支持MSRS作为MS相关恢复力的潜在结果衡量标准的效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Establishing the Test-Retest Reliability and Minimal Detectable Change of the Multiple Sclerosis Resiliency Scale.

Background: The Multiple Sclerosis Resiliency Scale (MSRS) was designed to assess factors connected to resilience when facing MS-related challenges. Although the MSRS has demonstrated good internal consistency and construct validity, its test-retest reliability has yet to be established. Identifying the minimal detectable change (MDC) of the scale will also improve its utility as an outcome measure for resilience-based interventions. This study aimed to determine the test-retest reliability and MDC of the MSRS.

Methods: Participants were 62 persons with MS who completed the MSRS twice, with a mean ± SD of 16.60 ± 3.97 days (range, 14-30 days) between assessments. Test-retest reliability was evaluated using a 2-way, random-effects, single-measurement intraclass correlation coefficient (ICC), with agreement between time 1 and time 2 visualized with a Bland-Altman plot. The MDC was calculated using the standard error of measurement with a 95% CI.

Results: At time 1, the mean ± SD MSRS score was 77.19 ± 11.97 (range, 45.83-97.00); at time 2, the mean ± SD score was 76.38 ± 12.75 (range, 46-98). The MSRS total score had good test-retest reliability (ICC = 0.88), with the subscale ICCs ranging from 0.77 (MS Peer Support) to 0.93 (Spirituality). The MDC for the total score was 11.95.

Conclusions: These findings suggest that the MSRS has good test-retest reliability and that persons with MS with a difference of 12 points or more between assessments have experienced a reliable change. The results support the utility of the MSRS as a potential outcome measure for MS-related resilience.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International journal of MS care
International journal of MS care Nursing-Advanced and Specialized Nursing
CiteScore
3.00
自引率
0.00%
发文量
40
期刊最新文献
Impact of Fingolimod Discontinuation Strategy on Recurrence of Disease Activity in Individuals With Multiple Sclerosis. Expanding the Connection Between Cognition and Illness Intrusiveness in Multiple Sclerosis. Cognitive Function in Frail Older Adults With Multiple Sclerosis: An Exploratory Study Using Secondary Data Analysis. Exploring the Complexity of Falls in People With Multiple Sclerosis: A Qualitative Study. Reasons for Hospital Admission in Individuals With Multiple Sclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1